Modified polynucleotides encoding aquaporin-5
View Patent ↗The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and modified mRNA (mmRNA) molecules.
1. A method of producing Aquaporin-5 in a mammalian cell, tissue or organism comprising contacting said mammalian cell, tissue or organism with an mRNA encoding SEQ ID NO: 821, wherein said mRNA comprises a coding region having at least 80% identity to SEQ ID NO: 6594.
2. The method of claim 1 , wherein the mRNA comprises at least one untranslated region 5′ relative to the coding region and at least one untranslated region 3′ relative to the coding region.
3. The method of claim 2 , wherein the 5′ untranslated region is heterologous to the coding region of the mRNA.
4. The method of claim 2 , wherein the 3′ untranslated region is heterologous to the coding region of the mRNA.
5. The method of claim 2 , wherein the 5′ untranslated region and the 3′ untranslated region are heterologous to the coding region of the mRNA.
6. The method of claim 2 , wherein the mRNA comprises at least two stop codons.
7. The method of claim 1 , wherein the coding region is selected from the group consisting of SEQ ID NO: 6594, 6574, 6584, 6606, 6612, 6613 and 6617.